vs

Side-by-side financial comparison of Dayforce (DAY) and Enovis CORP (ENOV). Click either name above to swap in a different company.

Enovis CORP is the larger business by last-quarter revenue ($548.9M vs $481.6M, roughly 1.1× Dayforce). Dayforce runs the higher net margin — -40.9% vs -104.1%, a 63.2% gap on every dollar of revenue. On growth, Dayforce posted the faster year-over-year revenue change (9.5% vs -2.2%). Over the past eight quarters, Enovis CORP's revenue compounded faster (9.8% CAGR vs 9.8%).

Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

DAY vs ENOV — Head-to-Head

Bigger by revenue
ENOV
ENOV
1.1× larger
ENOV
$548.9M
$481.6M
DAY
Growing faster (revenue YoY)
DAY
DAY
+11.6% gap
DAY
9.5%
-2.2%
ENOV
Higher net margin
DAY
DAY
63.2% more per $
DAY
-40.9%
-104.1%
ENOV
Faster 2-yr revenue CAGR
ENOV
ENOV
Annualised
ENOV
9.8%
9.8%
DAY

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
DAY
DAY
ENOV
ENOV
Revenue
$481.6M
$548.9M
Net Profit
$-196.8M
$-571.1M
Gross Margin
59.9%
Operating Margin
6.3%
-101.7%
Net Margin
-40.9%
-104.1%
Revenue YoY
9.5%
-2.2%
Net Profit YoY
-9940.0%
18.8%
EPS (diluted)
$-1.23
$-9.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAY
DAY
ENOV
ENOV
Q4 25
$548.9M
Q3 25
$481.6M
$564.5M
Q2 25
$464.7M
$558.8M
Q1 25
$481.8M
Q4 24
$465.2M
$561.0M
Q3 24
$440.0M
$505.2M
Q2 24
$423.3M
$525.2M
Q1 24
$431.5M
$516.3M
Net Profit
DAY
DAY
ENOV
ENOV
Q4 25
$-571.1M
Q3 25
$-196.8M
$-36.7M
Q2 25
$21.3M
$-56.0M
Q1 25
$14.9M
Q4 24
$10.8M
$-703.2M
Q3 24
$2.0M
$-31.5M
Q2 24
$-1.8M
$-18.6M
Q1 24
$7.1M
$-72.0M
Gross Margin
DAY
DAY
ENOV
ENOV
Q4 25
59.9%
Q3 25
59.3%
Q2 25
59.5%
Q1 25
Q4 24
47.0%
54.8%
Q3 24
45.8%
56.7%
Q2 24
44.1%
55.0%
Q1 24
47.6%
57.7%
Operating Margin
DAY
DAY
ENOV
ENOV
Q4 25
-101.7%
Q3 25
6.3%
-3.0%
Q2 25
9.1%
-8.4%
Q1 25
6.4%
Q4 24
6.1%
-118.5%
Q3 24
4.7%
-6.3%
Q2 24
3.3%
-8.4%
Q1 24
9.4%
-6.8%
Net Margin
DAY
DAY
ENOV
ENOV
Q4 25
-104.1%
Q3 25
-40.9%
-6.5%
Q2 25
4.6%
-10.0%
Q1 25
3.1%
Q4 24
2.3%
-125.4%
Q3 24
0.5%
-6.2%
Q2 24
-0.4%
-3.5%
Q1 24
1.6%
-13.9%
EPS (diluted)
DAY
DAY
ENOV
ENOV
Q4 25
$-9.99
Q3 25
$-1.23
$-0.64
Q2 25
$0.13
$-0.98
Q1 25
$0.09
Q4 24
$0.07
$-12.69
Q3 24
$0.01
$-0.58
Q2 24
$-0.01
$-0.34
Q1 24
$0.04
$-1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAY
DAY
ENOV
ENOV
Cash + ST InvestmentsLiquidity on hand
$627.6M
$33.6M
Total DebtLower is stronger
$631.1M
$1.4B
Stockholders' EquityBook value
$2.7B
$2.0B
Total Assets
$8.7B
$4.4B
Debt / EquityLower = less leverage
0.23×
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAY
DAY
ENOV
ENOV
Q4 25
$33.6M
Q3 25
$627.6M
$44.1M
Q2 25
$625.2M
$38.5M
Q1 25
$557.3M
Q4 24
$579.7M
$48.2M
Q3 24
$494.1M
$35.4M
Q2 24
$465.4M
$35.0M
Q1 24
$392.5M
$66.3M
Total Debt
DAY
DAY
ENOV
ENOV
Q4 25
$1.4B
Q3 25
$631.1M
$1.4B
Q2 25
$631.8M
$1.4B
Q1 25
$632.4M
Q4 24
$1.2B
$1.3B
Q3 24
$1.2B
$1.3B
Q2 24
$1.2B
$1.3B
Q1 24
$1.2B
$1.3B
Stockholders' Equity
DAY
DAY
ENOV
ENOV
Q4 25
$2.0B
Q3 25
$2.7B
$2.6B
Q2 25
$2.7B
$2.6B
Q1 25
$2.6B
Q4 24
$2.5B
$2.6B
Q3 24
$2.6B
$3.3B
Q2 24
$2.5B
$3.3B
Q1 24
$2.4B
$3.3B
Total Assets
DAY
DAY
ENOV
ENOV
Q4 25
$4.4B
Q3 25
$8.7B
$5.0B
Q2 25
$8.5B
$4.9B
Q1 25
$9.5B
Q4 24
$9.1B
$4.7B
Q3 24
$8.1B
$5.6B
Q2 24
$9.0B
$5.4B
Q1 24
$10.8B
$5.5B
Debt / Equity
DAY
DAY
ENOV
ENOV
Q4 25
0.67×
Q3 25
0.23×
0.54×
Q2 25
0.23×
0.53×
Q1 25
0.24×
Q4 24
0.47×
0.52×
Q3 24
0.47×
0.40×
Q2 24
0.49×
0.41×
Q1 24
0.50×
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAY
DAY
ENOV
ENOV
Operating Cash FlowLast quarter
$31.2M
$82.6M
Free Cash FlowOCF − Capex
$29.1M
FCF MarginFCF / Revenue
5.3%
Capex IntensityCapex / Revenue
9.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAY
DAY
ENOV
ENOV
Q4 25
$82.6M
Q3 25
$31.2M
$47.8M
Q2 25
$112.7M
$-1.6M
Q1 25
$49.6M
Q4 24
$81.0M
$88.3M
Q3 24
$91.8M
$53.6M
Q2 24
$99.2M
$7.8M
Q1 24
$9.1M
$-36.2M
Free Cash Flow
DAY
DAY
ENOV
ENOV
Q4 25
$29.1M
Q3 25
$3.4M
Q2 25
$-44.9M
Q1 25
Q4 24
$35.1M
Q3 24
$2.4M
Q2 24
$-31.6M
Q1 24
$-73.1M
FCF Margin
DAY
DAY
ENOV
ENOV
Q4 25
5.3%
Q3 25
0.6%
Q2 25
-8.0%
Q1 25
Q4 24
6.3%
Q3 24
0.5%
Q2 24
-6.0%
Q1 24
-14.2%
Capex Intensity
DAY
DAY
ENOV
ENOV
Q4 25
9.7%
Q3 25
7.9%
Q2 25
7.7%
Q1 25
Q4 24
9.5%
Q3 24
10.1%
Q2 24
7.5%
Q1 24
7.2%
Cash Conversion
DAY
DAY
ENOV
ENOV
Q4 25
Q3 25
Q2 25
5.29×
Q1 25
3.33×
Q4 24
7.50×
Q3 24
45.90×
Q2 24
Q1 24
1.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAY
DAY

Dayforce Recurring$333.0M69%
Cloud And Bureau Professional Services And Other$78.5M16%
Float$42.2M9%
Powerpay Recurring$19.7M4%
Other Recurring$8.2M2%

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

Related Comparisons